Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.

Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins.

The expression of lactate dehydrogenase 5 (LDH5), the major LDH isoenzyme sustaining the anaerobic transformation glycolysis was examined in B-cell non-Hodgkin lymphomas. Multi-tissue slides obtained from patients with diffuse large B-cell lymphomas (DLBCL; 95 cases), follicular lymphomas (FL; 49 ca...

Full description

Bibliographic Details
Main Authors:	Giatromanolaki, A, Koukourakis, M, Pezzella, F, Sivridis, E, Turley, H, Harris, A, Gatter, K
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation.
by: Giatromanolaki, A, et al.
Published: (2008)

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.
by: Koukourakis, M, et al.
Published: (2003)

Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
by: Koukourakis, M, et al.
Published: (2006)

Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy
by: Koukourakis, MI, et al.
Published: (2009)

Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma.
by: Stewart, M, et al.
Published: (2002)

Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma.
by: Koukourakis, M, et al.
Published: (2005)

Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy.
by: Koukourakis, M, et al.
Published: (2011)

BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer.
by: Giatromanolaki, A, et al.
Published: (2004)

Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas.
by: Giatromanolaki, A, et al.
Published: (2013)

BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis.
by: Giatromanolaki, A, et al.
Published: (2008)

BNIP3 expression in follicular lymphoma.
by: Sington, J, et al.
Published: (2007)

PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer.
by: Wigfield, S, et al.
Published: (2008)

DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.
by: Giatromanolaki, A, et al.
Published: (2003)

Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
by: Giatromanolaki, A, et al.
Published: (2001)

Hypoxia inducible factors 1alpha and 2alpha are associated with VEGF expression and angiogenesis in gallbladder carcinomas.
by: Giatromanolaki, A, et al.
Published: (2006)

Autophagy and hypoxia in colonic adenomas related to aggressive features.
by: Giatromanolaki, A, et al.
Published: (2013)

Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.
by: Koukourakis, M, et al.
Published: (2004)

Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.
by: Giatromanolaki, A, et al.
Published: (2003)

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
by: Sivridis, E, et al.
Published: (2002)

Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma.
by: Pezzella, F, et al.
Published: (1993)

Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells
by: Ikeda, Jun-ichiro, et al.
Published: (2012)

Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma.
by: Passalidou, E, et al.
Published: (2003)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia.
by: Koukourakis, M, et al.
Published: (2010)

Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.
by: Koukourakis, M, et al.
Published: (2003)

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.
by: Koukourakis, M, et al.
Published: (2002)

Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
by: Koukourakis, M, et al.
Published: (2006)

c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent.
by: Giatromanolaki, A, et al.
Published: (2004)

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.
by: Giatromanolaki, A, et al.
Published: (2008)

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway
by: Giatromanolaki, A, et al.
Published: (2008)

Macrophages in Hodgkin's lymphoma.
by: Pazianas, M
Published: (2010)

Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.
by: Kocialkowski, S, et al.
Published: (1995)

High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC).
by: Koukourakis, M, et al.
Published: (2013)

Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression.
by: Giatromanolaki, A, et al.
Published: (2006)

Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.
by: Giatromanolaki, A, et al.
Published: (2003)

Macrophages in Hodgkin's lymphoma [2]
by: Pazianas, M
Published: (2010)

Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis.
by: Giatromanolaki, A, et al.
Published: (2003)

Expression of phosphorylated (activated) receptors of vascular endothelial growth factor (VEGFR2/KDR) in colorectal cancer
by: Giatromanolaki, A, et al.
Published: (2007)

Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis.
by: Sivridis, E, et al.
Published: (2002)

Vascular endothelial growth factor expression in lung cancer.
by: O'Byrne, K, et al.
Published: (1998)

The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.
by: Brown, P, et al.
Published: (2005)